<DOC>
	<DOCNO>NCT00870168</DOCNO>
	<brief_summary>RATIONALE : Studying biopsy sample laboratory patient cancer may help doctor learn change occur DNA identify biomarkers related cancer . PURPOSE : This clinical trial study biopsy sample woman receive first-line chemotherapy metastatic breast cancer .</brief_summary>
	<brief_title>Studying Biopsy Samples Women Undergoing First-Line Chemotherapy Metastatic Breast Cancer</brief_title>
	<detailed_description>OBJECTIVES : Primary - Evaluate effect first-line chemotherapy expression hormone receptor biomarkers woman metastatic breast cancer . Secondary - Assess change HER1 HER2 expression treatment . OUTLINE : This multicenter study . Patients receive 6-9 course front-line chemotherapy accord investigator . Patients estrogen receptor- and/or progesterone receptor-positive disease receive hormone therapy . Patients undergo biopsy prior completion chemotherapy examination hormone receptor HER1 HER2 expression . After completion study treatment , patient follow every 6 month 5 year .</detailed_description>
	<mesh_term>Breast Neoplasms</mesh_term>
	<criteria>DISEASE CHARACTERISTICS : Histologically confirm adenocarcinoma breast Metastatic disease No inflammatory breast cancer Measurable disease accord RECIST criterion Hormone receptor status : Estrogen receptor and/or progesterone receptornegative IHC PATIENT CHARACTERISTICS : Menopausal status specify WHO performance status 02 Life expectancy &gt; 3 month ANC &gt; 1.5 x 10^9/L Platelet count &gt; 100 x 10^9/L Liver transaminase ≤ 3 time upper limit normal ( ULN ) Alkaline phosphatase ≤ 3 time ULN Bilirubin ≤ 1.5 time ULN Creatinine ≤ 2 time ULN Not pregnant nursing Fertile patient must use effective contraception No allergy xylocaine No heart failure , kidney , bone marrow , respiratory , liver insufficiency PRIOR CONCURRENT THERAPY : No prior firstline treatment metastatic disease</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2009</verification_date>
	<keyword>stage IV breast cancer</keyword>
	<keyword>estrogen receptor-negative breast cancer</keyword>
	<keyword>progesterone receptor-negative breast cancer</keyword>
</DOC>